{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T08:30:48Z","timestamp":1776501048263,"version":"3.51.2"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["24269"],"award-info":[{"award-number":["24269"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.micpath.2017.03.025","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T14:45:59Z","timestamp":1490625959000},"page":"682-687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["In\u00a0vitro evaluation of cross-strain inhibitory effects of IgY polyclonal antibody against H.\u00a0pylori"],"prefix":"10.1016","volume":"110","author":[{"given":"Roya","family":"Solhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7474-2515","authenticated-orcid":false,"given":"Masoud","family":"Alebouyeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abolfazl","family":"Khafri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morteza","family":"Rezaeifard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Aminian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2017.03.025_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hel.12165","article-title":"Epidemiology of Helicobacter pylori infection","volume":"19","author":"Eusebi","year":"2014","journal-title":"Helicobacter"},{"key":"10.1016\/j.micpath.2017.03.025_bib2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2036.2007.03573.x","article-title":"Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients","volume":"27","author":"Gisbert","year":"2008","journal-title":"Alimentary Pharmacol. Ther."},{"key":"10.1016\/j.micpath.2017.03.025_bib3","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0016-5085(98)70100-3","article-title":"Antibiotic resistance in Helicobacter pylori: implications for therapy","volume":"115","author":"Graham","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micpath.2017.03.025_bib4","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0016-5085(97)70028-3","article-title":"MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein","volume":"112","author":"Eck","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micpath.2017.03.025_bib5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","article-title":"Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma","volume":"338","author":"Wotherspoon","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2017.03.025_bib6","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1572-0241.1999.01360.x","article-title":"Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis","volume":"94","author":"Eslick","year":"1999","journal-title":"Am. J. Gastroenterology"},{"key":"10.1016\/j.micpath.2017.03.025_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc703","article-title":"Helicobacter pylori and gastrointestinal tract adenocarcinomas","volume":"2","author":"Peek","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.micpath.2017.03.025_bib8","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","article-title":"Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor \u03b1","volume":"36","author":"Elliott","year":"1993","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.micpath.2017.03.025_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJMoa0907635","article-title":"Treatment with monoclonal antibodies against Clostridium difficile toxins","volume":"362","author":"Lowy","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.micpath.2017.03.025_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0016-5085(95)90277-5","article-title":"Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)","volume":"109","author":"Van Dullemen","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micpath.2017.03.025_bib11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/ps\/84.4.660","article-title":"Antibodies: an alternative for antibiotics?","volume":"84","author":"Berghman","year":"2005","journal-title":"Poult. Sci."},{"key":"10.1016\/j.micpath.2017.03.025_bib12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/ilar.46.3.258","article-title":"Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources","volume":"46","author":"Lipman","year":"2005","journal-title":"ILAR J."},{"key":"10.1016\/j.micpath.2017.03.025_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.biologicals.2012.05.003","article-title":"Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy","volume":"40","author":"Spillner","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.micpath.2017.03.025_bib14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.17485\/ijst\/2010\/v3i4.24","article-title":"Chicken egg yolk antibodies (IgY) as an alternative to mammalian antibodies","volume":"3","author":"Michael","year":"2010","journal-title":"Indian J. Sci. Technol."},{"key":"10.1016\/j.micpath.2017.03.025_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-food-022811-101137","article-title":"Egg yolk antibodies for passive immunity","volume":"3","author":"Kovacs-Nolan","year":"2012","journal-title":"Annu. Rev. food Sci. Technol."},{"key":"10.1016\/j.micpath.2017.03.025_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02931933","article-title":"Inhibition of growth and adhesion ofHelicobacter pylori using egg yolk antibodies","volume":"4","author":"Koo","year":"1999","journal-title":"Biotechnol. Bioprocess Eng."},{"key":"10.1016\/j.micpath.2017.03.025_bib17","first-page":"1061","article-title":"Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection","volume":"9","author":"Shin","year":"2002","journal-title":"Clin. Diagnostic Laboratory Immunol."},{"key":"10.1016\/j.micpath.2017.03.025_bib18","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1128\/iai.59.7.2470-2475.1991","article-title":"Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets","volume":"59","author":"Eaton","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2017.03.025_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1099\/jmm.0.05327-0","article-title":"Production of anti-Helicobacter pylori urease-specific immunoglobulin in egg yolk using an antigenic epitope of H.\u00a0pylori urease","volume":"53","author":"Shin","year":"2004","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.micpath.2017.03.025_bib20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.micpath.2011.06.002","article-title":"Treatment of Helicobacter pylori infection in mice with oral administration of egg yolk-driven anti-UreC immunoglobulin","volume":"51","author":"Malekshahi","year":"2011","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2017.03.025_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01969526","article-title":"Microbiological aspects ofHelicobacter pylori (Campylobacter pylori)","volume":"9","author":"Goodwin","year":"1990","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2017.03.025_bib22","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1128\/IAI.70.11.6383-6388.2002","article-title":"Protection against experimental Helicobacter pylori infection after immunization with inactivated H.\u00a0pylori whole-cell vaccines","volume":"70","author":"Raghavan","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2017.03.025_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0022-1759(93)90179-B","article-title":"Comparison of four purification methods for the production of immunoglobulins from eggs laid by hens immunized with an enterotoxigenic E. coli strain","volume":"160","author":"Akita","year":"1993","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.micpath.2017.03.025_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ab.2012.11.014","article-title":"Mechanism of Coomassie Brilliant Blue G-250 binding to cetyltrimethylammonium bromide: an interference with the Bradford assay","volume":"434","author":"Aminian","year":"2013","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.micpath.2017.03.025_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/08820138509022667","article-title":"Improvements in the isolation of IgY from the yolks of eggs laid by immunized hens","volume":"14","author":"Polson","year":"1985","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.micpath.2017.03.025_bib26","first-page":"1","article-title":"IgY technology: extraction of chicken antibodies from egg yolk by polyethylene glycol (PEG) precipitation","volume":"51","author":"Pauly","year":"2011","journal-title":"JoVE J. Vis. Exp."},{"key":"10.1016\/j.micpath.2017.03.025_bib27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2017.03.025_bib28","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1365-2621.2002.tb10310.x","article-title":"Growth inhibitory effect of chicken egg yolk antibody (IgY) on Escherichia coli O157: H7","volume":"67","author":"Sunwoo","year":"2002","journal-title":"J.\u00a0Food Sci."},{"key":"10.1016\/j.micpath.2017.03.025_bib29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/ps\/81.5.632","article-title":"In\u00a0vitro studies of chicken egg yolk antibody (IgY) against Salmonella enteritidis and Salmonella typhimurium","volume":"81","author":"Lee","year":"2002","journal-title":"Poult. Sci."},{"key":"10.1016\/j.micpath.2017.03.025_bib30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ppul.10290","article-title":"Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: a phase I feasibility study","volume":"35","author":"Kollberg","year":"2003","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.micpath.2017.03.025_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3382\/ps.2007-00252","article-title":"Production of hen egg yolk immunoglobulins simultaneously directed against Salmonella Enteritidis and Salmonella Typhimurium in the same egg yolk","volume":"87","author":"Chalghoumi","year":"2008","journal-title":"Poult. Sci."},{"key":"10.1016\/j.micpath.2017.03.025_bib32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1523-5378.2011.00831.x","article-title":"Identification of Helicobacter pylori strain cagPAI+ and cagPAI\u2212 antigens by IgG antibodies from sera of experimentally colonized Meriones unguiculatus (Mongolian gerbils)","volume":"16","author":"Z\u00e1rate-Aquino","year":"2011","journal-title":"Helicobacter"},{"key":"10.1016\/j.micpath.2017.03.025_bib33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/cdli.4.5.592-597.1997","article-title":"Antigenic characterization of Helicobacter pylori strains from different parts of the world","volume":"4","author":"H\u00f6\u00f6k-Nikanne","year":"1997","journal-title":"Clin. Diagnostic Laboratory Immunol."},{"key":"10.1016\/j.micpath.2017.03.025_bib34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev.immunol.19.1.523","article-title":"The design of vaccines against Helicobacter pylori and their development","volume":"19","author":"Del Giudice","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.micpath.2017.03.025_bib35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0966-842X(03)00024-6","article-title":"Helicobacter pylori virulence factors and the host immune response: implications for therapeutic vaccination","volume":"11","author":"Prinz","year":"2003","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.micpath.2017.03.025_bib36","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1128\/IAI.69.6.3581-3590.2001","article-title":"Safety and immunogenicity of oral inactivated whole-CellHelicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection","volume":"69","author":"Kotloff","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2017.03.025_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.iy.02.040184.002143","article-title":"Antigen-presenting function of the macrophage","volume":"2","author":"Unanue","year":"1984","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.micpath.2017.03.025_bib38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00054-05","article-title":"Pathogenesis of Helicobacter pylori infection","volume":"19","author":"Kusters","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2017.03.025_bib39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s12038-009-0069-4","article-title":"Helicobacter urease: niche construction at the single molecule level","volume":"34","author":"Khan","year":"2009","journal-title":"J.\u00a0Biosci."},{"key":"10.1016\/j.micpath.2017.03.025_bib40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/jcm.30.3.739-741.1992","article-title":"Use of polymerase chain reaction-amplified Helicobacter pylori urease structural genes for differentiation of isolates","volume":"30","author":"Foxall","year":"1992","journal-title":"J.\u00a0Clin. Microbiol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401016308610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401016308610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T15:34:51Z","timestamp":1656776091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401016308610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":40,"alternative-id":["S0882401016308610"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2017.03.025","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vitro evaluation of cross-strain inhibitory effects of IgY polyclonal antibody against H.\u00a0pylori","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2017.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}